Feb 10, 2023 06:27PM
Dec 22, 2022 07:41AM
Dec 6, 2022 07:00AM
Nov 29, 2022 07:00AM
Nov 18, 2022 12:23PM
Oct 27, 2022 01:57PM
Oct 11, 2022 07:42AM Tetra and Prepaire Jointly Apply to BARDA for Funding
Sep 8, 2022 07:44AM
Sep 6, 2022 09:13AM
Aug 11, 2022 10:19PM
Aug 10, 2022 06:30AM
Jul 12, 2022 07:30AM
Jul 12, 2022 07:30AM
Jun 6, 2022 07:33AM Tetra Bio-Pharma Opens New Subsidiary in Australia and Provides Regulatory Update
May 31, 2022 10:38AM
May 30, 2022 07:44AM
May 18, 2022 07:56AM
May 17, 2022 11:14AM
May 10, 2022 07:00AM
May 5, 2022 06:30AM
Mar 17, 2022 06:30AM Tetra Bio-Pharma's QIXLEEF™ on Track After Type C Meeting with U.S. FDA
Mar 8, 2022 06:30AM
Feb 22, 2022 06:30AM
Feb 16, 2022 06:30AM
Feb 14, 2022 07:30AM
Feb 14, 2022 07:00AM
Nov 29, 2021 02:21PM
Nov 29, 2021 06:30AM Tetra Bio-Pharma Announces Positive Initial Clinical Data from Both of its Ongoing Phase 2 Clinical Trials of QIXLEEF™
Nov 4, 2021 08:00PM
Oct 21, 2021 06:30AM
Oct 14, 2021 06:30AM
Oct 5, 2021 07:30AM
Sep 2, 2021 06:30AM
Jul 29, 2021 07:30AM
Jul 22, 2021 09:00AM Tetra Bio-Pharma Engages Christine Caron as Patient Partner
Jul 12, 2021 07:30AM
Jun 21, 2021 06:30AM
Oct 21, 2020 07:00AM
May 15, 2020 10:41AM
May 14, 2020 03:46PM
Apr 6, 2020 08:00AM
Apr 2, 2020 08:00AM Tetra Bio-Pharma Maps Out Cannabinoid Metabolites in Humans Following Inhalation of QIXLEEF
Mar 30, 2020 09:20AM
Mar 26, 2020 07:00AM
Mar 23, 2020 08:00AM
Mar 6, 2020 08:00AM
Feb 25, 2020 08:00AM
Feb 24, 2020 08:00AM
Feb 20, 2020 08:00AM Tetra Bio-Pharma Initiates a Proof of Concept Clinical Trial for its Ophthalmic Drug in Dogs
Feb 18, 2020 08:00AM

325,591 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All